BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

921 related articles for article (PubMed ID: 10668287)

  • 1. [High prevalence of undiagnosed primary hyperaldosteronism among patients with essential hypertension].
    Mosso L; Fardella C; Montero J; Rojas P; Sánchez O; Rojas V; Rojas A; Huete A; Soto J; Foradori A
    Rev Med Chil; 1999 Jul; 127(7):800-6. PubMed ID: 10668287
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Normokalemic hyperaldosteronism in patients with resistant hypertension.
    Benchetrit S; Bernheim J; Podjarny E
    Isr Med Assoc J; 2002 Jan; 4(1):17-20. PubMed ID: 11802302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of primary aldosteronism among unselected hypertensive patients: a prospective study based on the use of an aldosterone/renin ratio above 25 as a screening test.
    Fogari R; Preti P; Zoppi A; Rinaldi A; Fogari E; Mugellini A
    Hypertens Res; 2007 Feb; 30(2):111-7. PubMed ID: 17460380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Excess of mineralocorticoids in essential hypertension: clinical-diagnostic approach].
    Cortés P; Fardella C; Oestreicher E; Gac H; Mosso L; Soto J; Foradori A; Claverie X; Ahuad J; Montero J
    Rev Med Chil; 2000 Sep; 128(9):955-61. PubMed ID: 11349499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Primary hyperaldosteronism--12 clinical cases].
    Telles EC; Machado FS; da Silva EP; Lutucuta S; Almeida G; Coucelo J; Vagueiro C
    Rev Port Cardiol; 1999 Sep; 18(9):801-12. PubMed ID: 10536470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary aldosteronism.
    Fardella CE; Mosso L
    Clin Lab; 2002; 48(3-4):181-90. PubMed ID: 11934220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The diagnosis of primary aldosteronism and separation of two major subtypes.
    Weinberger MH; Fineberg NS
    Arch Intern Med; 1993 Sep; 153(18):2125-9. PubMed ID: 8379804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The aldosterone to Renin ratio in secondary hypertension].
    Seiler L; Reincke M
    Herz; 2003 Dec; 28(8):686-91. PubMed ID: 14689102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary aldosteronism: A common and curable form of hypertension.
    Young WF
    Cardiol Rev; 1999; 7(4):207-14. PubMed ID: 10423672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent advances in diagnosis and treatment of primary aldosteronism.
    Veglio F; Morello F; Rabbia F; Leotta G; Mulatero P
    Minerva Med; 2003 Aug; 94(4):259-65. PubMed ID: 14605590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma and urine aldosterone to plasma renin activity ratio in the diagnosis of primary aldosteronism.
    Bernini G; Moretti A; Orlandini C; Berti P; Miccoli P; Bardini M; Taurino C; Bernini M; Salvetti A
    J Hypertens; 2008 May; 26(5):981-8. PubMed ID: 18398341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of biochemical tests and clinical symptoms in differential diagnosis of primary aldosteronism.
    Prejbisz A; Postuła M; Cybulska I; Dobrucki T; Kabat M; Peczkowska M; Janas J; Janaszek-Sitkowska H; Makowiecka-Cieśla M; Januszkiewicz A
    Kardiol Pol; 2003 Jan; 58(1):17-26. PubMed ID: 14502298
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary aldosteronism: renaissance of a syndrome.
    Young WF
    Clin Endocrinol (Oxf); 2007 May; 66(5):607-18. PubMed ID: 17492946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selection of patients for surgery for primary aldosteronism.
    Plouin PF; Rossignol P; Amar L
    Clin Exp Pharmacol Physiol; 2008 Apr; 35(4):522-5. PubMed ID: 18307754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary hyperaldosteronism in essential hypertensives: prevalence, biochemical profile, and molecular biology.
    Fardella CE; Mosso L; Gómez-Sánchez C; Cortés P; Soto J; Gómez L; Pinto M; Huete A; Oestreicher E; Foradori A; Montero J
    J Clin Endocrinol Metab; 2000 May; 85(5):1863-7. PubMed ID: 10843166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The spironolactone, amiloride, losartan, and thiazide (SALT) double-blind crossover trial in patients with low-renin hypertension and elevated aldosterone-renin ratio.
    Hood SJ; Taylor KP; Ashby MJ; Brown MJ
    Circulation; 2007 Jul; 116(3):268-75. PubMed ID: 17606839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Aldosterone-to-renin ratio threshold for screening primary aldosteronism in Chinese hypertensive patients].
    Chen SX; Du YL; Zhang J; Gong YC; Hu YR; Chu SL; He QB; Song YY; Zhu DL
    Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Oct; 34(10):868-72. PubMed ID: 17217708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Aldosterone/plasma renin activity ratio is a sensitive parameter for screening patients with primary aldosteronism].
    Zhang HL; Liu ZJ; Shao JM; Yan JT; Wang DW
    Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Oct; 34(10):873-6. PubMed ID: 17217709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Aldosterone/renin ratio in the diagnosis of primary aldosteronism].
    Ríos MC; Izquierdo A; Sotelo M; Honnorat E; Rodríguez Cuimbra S; Catay E; Popescu BM
    Medicina (B Aires); 2011; 71(6):525-30. PubMed ID: 22167725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High frequency of primary hyperaldosteronism among hypertensive patients from a primary care area in Sweden.
    Westerdahl C; Bergenfelz A; Isaksson A; Wihl A; Nerbrand C; Valdemarsson S
    Scand J Prim Health Care; 2006 Sep; 24(3):154-9. PubMed ID: 16923624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 47.